Chien Fu Chen
Vermogen: 817 568 $ op 30-09-2026
Vermogen: 817 568 $ op 30-09-2026
Mr. Chien Fu Chen is on the Board of Directors at Taiwan Styrene Monomer Corp.
and Adimmune Corp.
Mr. Chen also served on the board at Enimmune Corp.
He received his undergraduate degree from the University of California, Berkeley and an MBA from Peking University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ENIMMUNE CORPORATION 2,23% | 30-09-2025 | 1.611.320 ( 2,23% ) | 817 568 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ADIMMUNE CORPORATION | Directeur/Bestuurslid | 29-06-2017 |
| TAIWAN STYRENE MONOMER CORPORATION | Directeur/Bestuurslid | 31-01-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ENIMMUNE CORPORATION | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Taiwan Styrene Monomer Corp.
Taiwan Styrene Monomer Corp. Chemicals: SpecialtyProcess Industries Manufactures styrene monomer, para-diethyl benzene, toluene and ethyl benzene | Process Industries |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adimmune Corp.
Adimmune Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures influenza vaccine | Health Technology |
Enimmune Corp.
Enimmune Corp. BiotechnologyHealth Technology Develops vaccine | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau